TNF and glioblastoma: The data showed that rChemerin-treated GSCs had higher Verhaak mesenchymal scores and several mesenchymal related GSVA scores with reference to GSCs treated with recombinant TNF-α (rTNF-α), a potent mesenchymal phenotype-promoting factor in GBM [24–26] (Fig. 2G).